Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jul;91(7):1098-104.
doi: 10.1016/j.apmr.2010.02.013.

Static magnetic field therapy for carpal tunnel syndrome: a feasibility study

Agatha P Colbert  1 , Marko S Markov, Nels Carlson, William L Gregory, Hans Carlson, Patricia J Elmer
Affiliations
Randomized Controlled Trial

Static magnetic field therapy for carpal tunnel syndrome: a feasibility study

Agatha P Colbert et al. Arch Phys Med Rehabil. 2010 Jul.

Abstract

Objectives: To assess the feasibility of conducting trials of static magnetic field (SMF) therapy for carpal tunnel syndrome (CTS), to collect preliminary data on the effectiveness of 2 SMF dosages, and to explore the influence of an SMF on median nerve conduction.

Design: Randomized, double-blind, sham-controlled trial with a 6-week intervention and a 12-week follow-up.

Setting: University hospital outpatient clinics.

Participants: Women and men (N=60), ages 21 to 65 years, with an electrophysiologically confirmed CTS diagnosis recruited from the general population.

Interventions: Participants wore nightly either neodymium magnets that delivered either 15 or 45 mTesla (mT) to the contents of the carpal canal or a nonmagnetic disk.

Main outcome measures: Symptom Severity Scale (SSS) and Function Severity Scale (FSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) and 4 median nerve parameters: sensory distal latency, sensory nerve action potential amplitude, motor distal latency and compound motor action potential amplitude.

Results: Fifty-eight of 60 randomized participants completed the study. There were no significant between-group differences for change in the primary endpoint SSS or for FSS or median nerve conduction parameters. For the SSS and the FSS, each group showed a reduction at 6 weeks indicating improvement in symptoms.

Conclusions: This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.

Trial registration: ClinicalTrials.gov NCT00521495.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Placement of permanent magnet on wrist
Figure 2
Figure 2
CONSORT Participant enrollment and flow chart
Figure 3
Figure 3
Success of blinding
See this image and copyright information in PMC

References

    1. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I. Prevalence of carpal tunnel syndrome in a general population. Jama. 1999;282(2):153–158. - PubMed
    1. Verdugo RJ, Salinas RA, Castillo JL, Cea JG. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev. 2008;(4) CD001552. - PMC - PubMed
    1. Bland JD. Treatment of carpal tunnel syndrome. Muscle Nerve. 2007;36(2):167–171. - PubMed
    1. Piazzini DB, Aprile I, Ferrara PE, Bertolini C, Tonali P, Maggi L, et al. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil. 2007;21(4):299–314. - PubMed
    1. Weintraub MI, Cole SP. Neuromagnetic treatment of pain in refractory carpal tunnel syndrome: An electrophysiological and placebo analysis. J Back Musculoskel Rehabil. 2000;15:77–81. - PubMed

Publication types

Associated data